Characterization of carbapenem-resistant Acinetobacter baumannii in Shanghai and Hong Kong

References

1. Afzal-Shah M., Livermore D. M. 1998; Worldwide emergence of carbapenem-resistant Acinetobacter spp. J Antimicrob Chemother 41:576–577 [CrossRef]
   [Google Scholar]
2. Afzal-Shah M., Woodford N., Livermore D. M. 2001; Characterization of OXA-25, OXA-26, and OXA-27, molecular class D β -lactamases associated with carbapenem resistance in clinical isolates of Acinetobacter baumannii . Antimicrob Agents Chemother 45:583–588 [CrossRef]
   [Google Scholar]
3. Bergogne-Berezin E., Towner K. J. 1996; Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin Microbiol Rev 9:148–165
   [Google Scholar]
4. Clark R. B. 1996; Imipenem resistance among Acinetobacter baumannii : association with reduced expression of a 33–36 KDa outer membrane protein. J Antimicrob Chemother 38:245–251 [CrossRef]
   [Google Scholar]
5. Clinical and Laboratory Standards Institute 2005 Performance Standards for Antimicrobial Susceptibility Testing: Fifteenth Informational Supplement M100-S15 Wayne, PA: Clinical and Laboratory Standards Institute;
   [Google Scholar]
6. Dimopoulou I. D., Kartali S. I., Kartalis G. N., Manolas K. I., Simopoulos K. E., Vargemezis B. A., Theodoropoulou-Rodiou G., Bowler I. C., Crook D. W. 2003; Relationship between nosocomial Acinetobacter species occurring in two geographical areas (Greece and the UK). J Hosp Infect 54:207–211 [CrossRef]
   [Google Scholar]
7. Donald H. M., Scaife W., Amyes S. G. B., Young H. K. 2000; Sequence analysis of ARI-1, a novel OXA β -lactamase, responsible for imipenem resistance in Acinetobacter baumanni 6B92. Antimicrob Agents Chemother 44:196–199 [CrossRef]
   [Google Scholar]
8. Héritier C., Poirel L., Lambert T., Nordmann P. 2005; Contribution of acquired carbapenem-hydrolyzing oxacillinases to carbapenem resistance in Acinetobacter baumannii . Antimicrob Agents Chemother 49:3198–3202 [CrossRef]
   [Google Scholar]
9. Jiang X., Yu J., Hong X. 2002; A clinical strain of Acinetobacter baumannii which produces OXA-23 carbapenemase and PER-1 type ESBLs. Shanghai J Med Lab Sci 17:263–267
   [Google Scholar]
10. Martín-Lozano D., Cisneros J. M., Becerril B., Cuberos L., Prados T., Ortíz-Leyba C., Cañas E., Pachón J. 2002; Comparison of a repetitive extragenic palindromic sequence-based PCR method and clinical and microbiological methods for determining strain sources in cases of nosocomial Acinetobacter baumannii bacteremia. J Clin Microbiol 40:4571–4575 [CrossRef]
    [Google Scholar]
11. Matthew M., Harris A. M., Marshall M., Ross G. W. 1975; The use of analytical isoelectric focusing for detection and identification of β -lactamases. J Gen Microbiol 88:169–178 [CrossRef]
    [Google Scholar]
12. National Commmittee for Clinical Laboratory Standards; 2003 Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically , 6th edn. Approved standard M7-A6 Wayne, PA: National Commmittee for Clinical Laboratory Standards;
    [Google Scholar]
13. Tenover F. C., Arbeit R., Archer G. 1995; Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 33:2233–2239
    [Google Scholar]
14. Vahaboglu H., Ozturk R., Aygun G., Coskunkan F. 1997; Widespread detection of PER-1-type extended-spectrum β -lactamases among nosocomial Acinetobacter and Pseudomonas aeruginosa isolates in Turkey: a nationwide multicenter study. Antimicrob Agents Chemother 41:2265–2269
    [Google Scholar]
15. Vaneechoutte M., Dijkshoorn L., Tjernberg I., Elaichouni A., De Vos P., Claeys G., Vershraegen G. 1995; Identification of Acinetobacter genomic species by amplified ribosomal DNA restriction analysis. J Clin Microbiol 33:11–15
    [Google Scholar]